Skip to content

Carter Lab: Microbial-based Therapeutics

Heersink School of Medicine

  • Home
  • Research
    • Projects
    • Funding
  • Members
  • News
  • Publications
  • Fun Times

08/17/2023: New publication! Bile acids and cocaine abuse!

Posted on August 17, 2023October 12, 2023

Check out our new report on the potential use of bile acids to decrease relapse in cocaine use disorder! https://rdcu.be/djJ2a

08/14/2023: Welcome Chibuzo Nwokafor, new GBS rotation student!

Posted on August 14, 2023October 12, 2023

Nwokafor, incoming GBS student in the Microbiology theme, joins the Carter Lab for his first rotation! Chibuzo is originally from Nigeria and just finished his Master of Science in Biotechnology in Scotland.

08/14/2023: New Funding for Microbial Research!

Posted on August 14, 2023October 12, 2023

“The Role of Microbiome Composition in Amphetamine Abuse,” is officially a funded NIDA R01! Let’s get busy Carter Lab and Gallivant Lab!

11/15/2022: Mabry and Zhu present at SfN 2022!

Posted on November 15, 2022October 12, 2023

Graduate students from the Gallivant Lab, Sam Mabry and Yanqi Zhu, present at the Society for Neuroscience Annual Meeting in San Diego, CA. Dopamine transporter regulation is cool!

Posts pagination

Previous page Page 1 Page 2

Search This Site

Recent News

  • 08/01/2024: Drs. Carter and Galli receive CNC Pilot Award!
  • 07/23/2024: Camila is selected to give a GRC talk!
  • 07/16/2024: El wins 2nd Place in the 3MT!
  • 04/12/2024: Nghi is selected for a travel award!
  • 03/18/2024: Welcome to the lab Nghi Dang!

Bookmarks

  • UAB Home

Accessibility Toolbar

Theme: Maisha Lite
UAB the University of Alabama at Birmingham home
  • Login
  • |
  • Privacy
  • |
  • Terms of Use
  • |
  • © 2025 The University of Alabama at Birmingham
UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.
Microbial-based Therapeutics Laboratory Department of Surgery - Division of Surgical Oncology Kaul Genetics Building 834